Table 1.
Patient characteristics of biomarker cohort of SAMIT study
Factors | UFT (n=124) |
S-1 (n=124) |
Pac-UFT (n=123) |
Pac-S-1 (n=128) |
P value | |||||
n | % | n | % | n | % | n | % | |||
Age | Median (range) | 65 (29–80) | 65 (38–80) | 66 (30–80) | 67(37–80) | 0.78 | ||||
Gender | Male | 87 | 70 | 77 | 62 | 86 | 70 | 93 | 73 | 0.31 |
Female | 37 | 30 | 47 | 38 | 37 | 30 | 35 | 27 | ||
Performance status | 0 | 107 | 86 | 103 | 83 | 101 | 82 | 105 | 82 | 0.77 |
1 | 17 | 14 | 21 | 17 | 22 | 18 | 23 | 18 | ||
Histological type | Differentiated | 45 | 36 | 52 | 42 | 49 | 40 | 55 | 43 | 0.73 |
Undifferentiated | 77 | 63 | 70 | 56 | 71 | 58 | 72 | 56 | ||
Other | 1 | 1 | 2 | 2 | 2 | 2 | 1 | 1 | ||
T stage | pT1 | 2 | 2 | 4 | 3 | 0 | 0 | 0 | 0 | 0.69 |
pT2 | 40 | 32 | 38 | 30 | 32 | 26 | 42 | 33 | ||
pT3 | 77 | 62 | 80 | 65 | 83 | 67 | 81 | 64 | ||
pT4 | 5 | 4 | 2 | 2 | 7 | 6 | 4 | 3 | ||
N stage | pN0 | 17 | 14 | 25 | 20 | 34 | 28 | 28 | 22 | 0.19 |
pN1 | 46 | 37 | 51 | 41 | 41 | 33 | 39 | 31 | ||
pN2 | 59 | 47 | 46 | 37 | 46 | 38 | 55 | 43 | ||
pN3 | 2 | 2 | 2 | 2 | 1 | 1 | 5 | 4 |
American Joint Committee on Cancer/Union for International Cancer Control (AJCC/UICC) sixth edition.